Table 2 Baseline demographics, duration of disease and therapy
UC N = 41 | Non UC N = 30 | |
|---|---|---|
Age (years) | ||
Mean (SD) | 39.3 (18.8) | 28.9 (11.0) |
Range | 24–60 | 21–62 |
Gender, male, n (%) | 21 (50) | 7 (25) |
Duration of UC (years) | ||
Mean (SD) | 11.42 (9.43) | |
Range | 1–37 | |
Treatment (current) | ||
TNFα-blocker | 21 | |
Glucocorticoids | 11 | |
Mesalazine | 24 | |
Immuno-suppressive | 7 | |
No | 4 | |